Fresenius Medical Care Ag ADR
(FMS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 919,715 | 574,064 | 264,431 | 1,259,800 | 857,028 |
| Depreciation Amortization | 536,651 | 356,813 | 175,854 | 699,320 | 513,487 |
| Income taxes - deferred | -103,203 | -72,560 | -52,797 | 113,790 | 1,657 |
| Accounts receivable | -242,093 | -142,494 | -93,507 | -276,211 | -201,091 |
| Accounts payable and accrued liabilities | 70,428 | 48,724 | 12,411 | 113,822 | 117,115 |
| Other Working Capital | 68,558 | -24,213 | 58,058 | -245,810 | -130,622 |
| Other Operating Activity | 161,668 | 92,116 | 82,820 | 196,679 | 116,246 |
| Operating Cash Flow | $1,411,724 | $832,450 | $447,270 | $1,861,390 | $1,273,820 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -636,183 | -411,437 | -197,617 | -919,950 | -638,739 |
| Net Acquisitions | -123,181 | -66,159 | -11,218 | 8,250 | -1,045,050 |
| Other Investing Activity | 0 | 0 | 0 | -1,779,050 | 0 |
| Investing Cash Flow | $-759,364 | $-477,596 | $-208,835 | $-2,690,750 | $-1,683,789 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 270,090 | 165,826 | 73,761 | 501,176 | 480,209 |
| Debt Issued | 5,972 | 4,191 | 1,860 | 2,910,611 | 1,616,470 |
| Debt Repayment | -264,693 | -138,625 | -60,850 | -1,647,978 | -1,118,729 |
| Common Stock Issued | 67,234 | 53,762 | 16,451 | 107,047 | 86,403 |
| Dividend Paid | -263,244 | -263,244 | N/A | -317,900 | -317,903 |
| Other Financing Activity | -449,630 | -215,686 | -268,511 | -747,946 | -438,436 |
| Financing Cash Flow | $-634,271 | $-393,776 | $-237,289 | $805,010 | $308,014 |
| Exchange Rate Effect | -30,567 | -12,774 | -12,079 | -24,570 | 6,682 |
| Beginning Cash Position | 633,855 | 633,855 | 633,855 | 682,770 | 682,777 |
| End Cash Position | 621,377 | 582,159 | 622,922 | 633,850 | 587,504 |
| Net Cash Flow | $-12,478 | $-51,696 | $-10,933 | $-48,920 | $-95,273 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,411,724 | 832,450 | 447,270 | 1,861,390 | 1,273,820 |
| Capital Expenditure | -647,350 | -417,751 | -201,196 | -931,627 | -646,371 |
| Free Cash Flow | 764,374 | 414,699 | 246,074 | 929,763 | 627,449 |